Evidence map›Paper›PMID 35451211›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

COVID-19 and transplantation-Data censoring.

Vijay Subramanian, Christopher Anderson, Seth Karp, Stephen Pastan, David Gerber, Jayme Locke, Ari Cohen, Malay Shah, Vincent Casingal, Robert Strata and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Data carve out in the midst of the COVID-19 pandemic.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  3. Transplant program evaluations in the middle of the COVID-19 pandemic.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  4. COVID-19 and transplantation-Data censoring.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Vijay SubramanianTransplant Institute, Tampa General Hospital, Tampa, Florida, USA.ORCID 0000-0003-2469-3094
Christopher AndersonUniversity of Mississippi Medical Center, Jackson, Mississippi, USA.
Seth KarpVanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-5266-1025
Stephen PastanEmory Transplant Center, Atlanta, Georgia, USA.ORCID 0000-0003-2638-6354
David GerberUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jayme LockeUniversity of Alabama School of Medicine, Birmingham, Alabama, USA.ORCID 0000-0002-0220-8716
Ari CohenOchsner Clinic Foundation, Jefferson, Louisiana, USA.
Malay ShahUniversity of Kentucky, Lexington, Kentucky, USA.ORCID 0000-0001-5325-2410
Vincent CasingalAtrium Health, Charlotte, North Carolina, USA.
Robert StrataAtrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA.ORCID 0000-0001-7634-094X
Neeraj SinghWillis-Knighton Medical Center, Shreveport, Louisiana, USA.
Derek DuBayMedical University of South Carolina, Mt Pleasant, South Carolina, USA.
Kiran DhanireddyTransplant Institute, Tampa General Hospital, Tampa, Florida, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the early wave of the COVID-19 pandemic, the Scientific Registry of Transplant Recipients (SRTR) designated a "black out" period between March 12, 2020, and June 12, 2020, for transplant outcomes reporting. We discuss the implications and potential bias it has introduced as it may selectively favor the outcomes for certain regions and harm other regions due to varied effects of different waves of COVID-19 infections across the United States.

Indexed as

COVID-19Organ TransplantationTissue and Organ ProcurementTransplantsHumansPandemicsRegistriesTransplant RecipientsUnited Stateseditorial/personal viewpointethics and public policylaw/legislationorgan transplantation in generalpatient survivalScientific Registry for Transplant Recipients (SRTR)

Identifiers

PMID35451211
PMCPMC9111342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.